Generics can’t stop heart drug cartel suit
A federal judge in New York held last week that indirect and direct purchasers had sufficiently alleged that several generic drugmakers orchestrated a scheme to fix and raise the price of propranolol hydrochloride.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10